- ICH GCP
- US Clinical Trials Registry
- Search trials
Søg i kliniske forsøg efter: TACE plus sorafenib
I alt 12345 resultater
-
Shanghai Zhongshan HospitalRekrutteringHepatocellulært karcinom | DonafenibKina
-
Guangxi Medical UniversityRekrutteringHepatocellulært karcinomKina
-
Acceleron Pharma Inc. (a wholly owned subsidiary...AfsluttetAvanceret hepatocellulært karcinom hos voksneForenede Stater
-
Eastern Hepatobiliary Surgery HospitalUkendtAvanceret hepatocellulært karcinomKina
-
Kindai UniversityUkendtCarcinom, hepatocellulært | Hepatocellulært karcinom | Neoplasma i leveren | Ikke-operabelt hepatocellulært karcinomJapan
-
Shenzhen SiBiono GeneTech Co.,LtdUkendtAvanceret hepatocellulært karcinom (HCC)Kina
-
Sun Yat-sen UniversityAfsluttetHepatocellulært karcinom | AnsigtskræftKina
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuHCC | Regorafenib | Transarteriel kemoembolisering | Hepatisk arteriel infusion Kemoterapi
-
Peking Union Medical College HospitalSuzhou Zelgen Biopharmaceuticals Co.,LtdIkke rekrutterer endnuHepatocellulært karcinomKina
-
Yale UniversityBayer; Biocompatibles UK LtdAfsluttetHepatocellulært karcinom | HepatomForenede Stater
-
Asan Medical CenterBayerUkendtHepatocellulært karcinom | MetastaseKorea, Republikken
-
Second Affiliated Hospital of Guangzhou Medical...AfsluttetHepatocellulært karcinom Ikke-operabeltKina
-
Chang Gung Memorial HospitalUkendtHepatocellulært karcinomTaiwan
-
BayerAfsluttetCarcinom, hepatocellulærtJapan, Kalkun, Østrig, Tjekkiet, Ungarn, Israel, Den Russiske Føderation, Slovakiet, Schweiz, Indien, Korea, Republikken, Frankrig, Mexico, Indonesien, Singapore, Thailand, Canada, Grækenland, Holland, Spanien, Taiwan, Polen, Brasilien, Ki... og mere
-
First Affiliated Hospital of Zhejiang UniversityRekrutteringIkke-operabelt hepatocellulært karcinom | Portal venetromboseKina
-
Southwest Hospital, ChinaUkendt
-
Sichuan Cancer Hospital and Research InstituteRekrutteringLeversygdomme | Neoplasmer i fordøjelsessystemet | Neoplasmer i leveren | Hepatocellulært karcinom | Antineoplastiske midler | Molekylære mekanismer for farmakologisk virkning | Proteinkinasehæmmere | SorafenibKina
-
Egyptian Society of Liver CancerAfsluttet
-
Tongji HospitalThe Second Affiliated Hospital of Fujian Medical University; Geneplus-Beijing... og andre samarbejdspartnereRekrutteringHepatocellulært karcinom Ikke-operabeltKina
-
Shanghai Zhongshan HospitalRekruttering
-
Sun Yat-sen UniversityAfsluttetHepatocellulært karcinom | Sorafenib | Transarteriel kemoemboliseringKina
-
Yabao Pharmaceutical GroupAfsluttet
-
Shandong Cancer Hospital and InstituteUkendtCarcinom, hepatocellulært | PHENYTOIN/SORAFENIB [VA lægemiddelinteraktion]Kina
-
Chinese PLA General HospitalUkendtHepatocellulært karcinomKina
-
PfizerTrukket tilbageKarcinom, nyrecelle | Glioblastom | Carcinom, hepatocellulært
-
Seoul National University HospitalAfsluttetHepatocellulært karcinomKorea, Republikken
-
Cancer Institute and Hospital, Chinese Academy...UkendtHepatocellulært karcinomKina
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnu
-
Air Force Military Medical University, ChinaUkendt
-
First Affiliated Hospital of Zhejiang UniversityBeiGene (Beijing) Co., LtdRekrutteringBCLC Stadium C Hepatocellulært karcinomKina
-
Sohag UniversityIkke rekrutterer endnu
-
Korea UniversityKorean Liver Cancer Study GroupUkendtHepatocellulært karcinom | MetastaseKorea, Republikken
-
Air Force Military Medical University, ChinaUkendt
-
Eastern Hepatobiliary Surgery HospitalAfsluttetHepatocellulært karcinomKina
-
Sun Yat-sen UniversityRekruttering
-
Chung-Ang UniversityGyeongsang National University HospitalUkendtHepatocellulært karcinomKorea, Republikken
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdTigermed Consulting Co., LtdAfsluttet
-
Shandong Cancer Hospital and InstituteUkendtLeversygdomme | Neoplasmer efter histologisk type | Neoplasmer efter sted | Adenocarcinom | Karcinom | Neoplasmer, kirtel og epitel | Neoplasmer i fordøjelsessystemet | Carcinom, hepatocellulært | Neoplasmer i leveren | HBV | PHENYTOIN/SORAFENIB [VA lægemiddelinteraktion] | DOXORUBICIN/TRASTUZUMAB [VA lægemiddelinteraktion]Kina
-
Peking University Cancer Hospital & InstituteRekrutteringAvanceret hepatocellulært karcinom (HCC)Kina
-
University of PittsburghBayerAfsluttetCarcinom, hepatocellulærtForenede Stater
-
Zhongda HospitalUkendtHepatocellulært karcinom | Portal venetumor tromboseKina
-
Boston Scientific CorporationAfsluttetHepatocellulært karcinom | Hepatom | LevercellekarcinomForenede Stater
-
Medical University of ViennaAfsluttetHepatocellulært karcinomØstrig
-
Lawson Health Research InstituteTrukket tilbage
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringAvanceret hepatocellulært karcinom | Strålebehandling | Sorafenib | ToripalimabKina
-
Beijing Tsinghua Chang Gung HospitalSuzhou Zelgen Biopharmaceuticals Co.,LtdRekrutteringHepatocellulært karcinomKina
-
Sun Yat-sen UniversityAktiv, ikke rekrutterende
-
Asan Medical CenterAfsluttetHepatocellulært karcinomKorea, Republikken
-
Nanfang Hospital of Southern Medical UniversityIkke rekrutterer endnuIkke-operabelt hepatocellulært karcinom